RDS is a pulmonary disorder resulting from a surfactant deficiency which commonly occurs ininfants whose lungs have not yet fully developped.
In Europe, RDS is observed for about 90% of babies born at 24 weeks of gestation and for 80% ofbabies born at 28 weeks of gestation.
Preterm infants should be managed without mechanical ventilation where possible CPAP with early rescue surfactant is considered optimal management for babies with RDS LISA is the preferred mode of surfactant administration for spontaneously breathing babies onCPAP, provided that clinicians are experienced with this technique
The paediatric endotracheal tubes without cuff (code 5516.xx) consist of:
AKSHAR PHARMA
All Rights Reserved.(Terms of Use) Developed and Managed by Infocom Network Private Limited. |